We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Earlier this year, on July 9, 2020, an agreement was reached with the Pierre-Fabre group for Fareva acquiring two pharmaceutical sterile manufacturing sites in France that the company expects to begin operation by the end of the year.